NCT06809439

Brief Summary

Periodontitis is a multifactorial, chronic inflammatory disease caused by many factors such as pathogenic microorganisms, host response, environmental and systemic factors. Immune mechanisms triggered by host-bacteria interaction can initiate tissue destruction by leading to the release of large amounts of inflammatory mediators such as IL-1β. It is thought that IL-10 has a regulatory role by limiting the initiation and progression of the acute inflammatory response with its anti-inflammatory effect. The high detection of RANKL and RANKL/OPG ratios in periodontitis indicates that these markers play a role in bone destruction. Elucidating the connections between the immune system and bone-related cytokines will contribute significantly to the resolution of these complex mechanisms underlying periodontal diseases. Risk factors for periodontal diseases include gender, age, smoking and some hereditary factors. Cortisol is an important marker of psychological stress. It is emphasized that stress and depression reduce immune system function and cause chronic inflammation. Thus, it indirectly provokes periodontal tissue destruction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
77

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 2, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 8, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 3, 2023

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

January 16, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

February 5, 2025

Completed
Last Updated

February 5, 2025

Status Verified

September 1, 2024

Enrollment Period

4 months

First QC Date

January 16, 2025

Last Update Submit

January 29, 2025

Conditions

Keywords

RANKLosteoprotegerininterleukin-10non-surgical periodontal therapyperiodontitissalivaenviromentalgeographical locations

Outcome Measures

Primary Outcomes (1)

  • Study population, pre-treatment and post-treatment periodontal clinical parameters

    This study included 10 systemically healthy non-smokers from Ankara with stage III, grade B generalized periodontitis, 8 smokers with stage III, grade C generalized periodontitis, 11 periodontally healthy non-smokers, and 11 periodontally healthy smokers. In Erzurum, systemically healthy, 9 non-smokers, stage III B generalized periodontitis , 6 smokers (≥10/day), stage III C generalized periodontitis, 11 periodontally healthy non-smokers, and 11 periodontally healthy smokers were included. Clinical parameters of probing depth (PPD), clinical attachment level (CAL), plaque index (PI), and bleeding on probing (BOP) were recorded . All clinical measurements were made after saliva samples were taken and recorded as initial values. The periodontal index form was used for this purpose. (https://www.periodontalchart-online.com/uk/) Nonsurgical periodontal treatments lasted 4 weeks. Baseline and post-treatment periodontal parameters were compared.

    up to 4 weeks

Secondary Outcomes (1)

  • Salivary biomarkers

    up to 2 months

Other Outcomes (9)

  • Determination of Pocket Depth (PD)

    up to 4 weeks

  • Determination of Clinical Attachment Level (CAL)

    up to 4 weeks

  • Determination of the Presence and Accumulation Level of Dental Plaque

    up to 4 weeks

  • +6 more other outcomes

Study Arms (4)

Control Ankara

EXPERIMENTAL

Healthy group at Ankara University. Total smokers and non-smokers with clinically healthy gingiva, no deep gingival pockets (≤3mm) and no attachment loss, no bleeding on probing or \<10%, no radiographic bone loss were included in the study. Clinical parameters were recorded and saliva was collected in this group.

Diagnostic Test: Saliva Collection (Baseline)Other: Probing

Control Atatürk

EXPERIMENTAL

Healthy group at Atatürk University. A total of patients with clinically healthy gums, no deep gingival pockets (≤3 mm) and attachment loss, no bleeding on probing or \<10%, no radiographic bone loss, smokers and non-smokers were included in the study. Clinical parameters were recorded and saliva was collected in this group.

Diagnostic Test: Saliva Collection (Baseline)Other: Probing

Periodontitis Ankara

EXPERIMENTAL

Smoker patient who applied to Ankara University, Faculty of Dentistry, Department of Periodontics, diagnosed with Stage III periodontitis with a clinically probed pocket depth of more than 5 mm and radiographically ≥3 mm bone loss, smoker patient diagnosed with Stage III.In this group, baseline and post-treatment clinical parameters were recorded and saliva was collected.

Procedure: Non-Surgical InterventionDiagnostic Test: Saliva Collection (Baseline)Other: ProbingDiagnostic Test: Saliva Collection (After treatment)

Periodontitis Atatürk

EXPERIMENTAL

Twenty-two patients who applied to the Department of Periodontics, Faculty of Dentistry, Ataturk University, and were diagnosed with Stage III Grade A periodontitis, 11 smokers and 11 smokers, with clinically probed pocket depths greater than 5 mm and radiographically ≥3 mm bone loss.

Procedure: Non-Surgical InterventionDiagnostic Test: Saliva Collection (Baseline)Other: ProbingDiagnostic Test: Saliva Collection (After treatment)

Interventions

Oral hygiene instructions including tooth brushing, flossing, and interdental brushing were given to all patient groups before non-surgical periodontal treatment. In both periodontitis groups, scaling, and root surface smoothing were performed using ultrasonic instruments (Woodpecker Medicals Ins. Co., USA) and Gracey Curettes (Hu-Friedy, Chicago, IL, USA) under local anesthesia once a week for 4 weeks.

Periodontitis AnkaraPeriodontitis Atatürk

Unstimulated saliva samples were collected from all participants between 9:00 and 11:00 am. Clinical periodontal measurements were performed after saliva collection to prevent contamination (bleeding, etc.). Participants refrained from brushing their teeth the morning before sampling and from eating, drinking, or smoking for at least 2 hours before sampling. Patients were asked to rinse their mouths with distilled water 5 minutes before saliva collection. A saliva sample was then collected by spitting directly into a sterile tube. Sample collection was continued for 5 minutes.

Control AnkaraControl AtatürkPeriodontitis AnkaraPeriodontitis Atatürk
ProbingOTHER

Clinical and radiographic evaluations were performed by trained and calibrated examiners at Ankara University (SY) and Ataturk University (OT). Clinical parameters of probing depth (PPD), clinical attachment level CAL, plaque index PI, and bleeding on probing (BOP) were recorded from six tooth regions (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, middle lingual, and disto-lingual) using periodontal probe. Bone loss was assessed using panoramic radiographs, confirming the diagnosis of periodontitis.

Control AnkaraControl AtatürkPeriodontitis AnkaraPeriodontitis Atatürk

Unstimulated saliva samples were collected from all participants between 9:00 and 11:00 am. Clinical periodontal measurements were performed after saliva collection to prevent contamination (bleeding, etc.). Participants refrained from brushing their teeth the morning before sampling and from eating, drinking, or smoking for at least 2 hours before sampling. Patients were asked to rinse their mouths with distilled water 5 minutes before saliva collection. A saliva sample was then collected by spitting directly into a sterile tube. Sample collection was continued for 5 minutes.

Periodontitis AnkaraPeriodontitis Atatürk

Eligibility Criteria

Age35 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years of age
  • good cooperation
  • a minimum of 20 permanent teeth, excluding third molars

You may not qualify if:

  • systemic diseases
  • taking any medications
  • received antibiotic treatment in the last three months
  • those who had undergone periodontal treatment six months ago
  • pregnant or breastfeeding patients
  • prosthetic restorations
  • undergoing orthodontic treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

AnkaraUniversity

Ankara, 06560, Turkey (Türkiye)

Location

Karabuk University

Karabük, 78100, Turkey (Türkiye)

Location

Related Publications (1)

  • Mengel R, Bacher M, Flores-De-Jacoby L. Interactions between stress, interleukin-1beta, interleukin-6 and cortisol in periodontally diseased patients. J Clin Periodontol. 2002 Nov;29(11):1012-22. doi: 10.1034/j.1600-051x.2002.291106.x.

    PMID: 12472994BACKGROUND

Related Links

MeSH Terms

Conditions

Tobacco SmokingAlveolar Bone LossPeriodontal DiseasesPeriodontitis

Condition Hierarchy (Ancestors)

SmokingBehaviorTobacco UseBone ResorptionBone DiseasesMusculoskeletal DiseasesPeriodontal AtrophyMouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: A total of 77 subjects in Ankara and Erzurum, 19 non-smokers (NS-P) with stage III, grade B generalized periodontitis and 14 smokers (SP) with stage III, grade C generalized periodontitis, as well as 22 non-smokers (NS-C) and 22 smokers (SC) periodontally healthy control cases were included in the study.Periodontal parameters were recorded, and unstimulated saliva samples were collected from all patients. Periodontitis patients (N=33) were evaluated clinically and biochemically (saliva IL-1β, cortisol, RANKL, OPG, and IL-10) 4 weeks after complete oral cleansing and root correction (SRP). Saliva samples were analyzed using enzyme-linked immunosorbent assay (ELISA). The data were analyzed using the SPSS software version 22.0.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst Prof Dr

Study Record Dates

First Submitted

January 16, 2025

First Posted

February 5, 2025

Study Start

January 2, 2023

Primary Completion

May 8, 2023

Study Completion

July 3, 2023

Last Updated

February 5, 2025

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

We plan to share the saliva biomarker statistics of the study as an excel file when requested. Our Turkish study protocol has also received approval (ethics committee decision).

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Start date: 2 January, 2023 End date: 2 January, 2028
Access Criteria
They may request the principal investigator to share the data of the study.

Locations